{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:35:23Z","timestamp":1760236523011,"version":"build-2065373602"},"reference-count":57,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Human endogenous retroviruses (HERVs), which are critical to normal embryologic development and downregulated during normal maturation, have been implicated in a variety of cancers. Abnormal persistent production of HERVs has been suggested to play a role in oncogenesis and to confer stem cell properties to cells. We recently demonstrated that the most recently incorporated HERV element (HERV-K HML-2) has been associated with the pathogenesis of the embryonal atypical teratoid rhabdoid tumor (AT\/RT), shifting our understanding of embryonal tumor development. HML-2 expression is vital for proper human development and its expression is suppressed via methylation or chromatin remodeling as cells differentiate. We previously found that dysfunctional chromatin remodeling due to loss of SMARCB1 expression induces HML-2 envelope (env) expression, impairing cellular differentiation and migration, and facilitating tumor growth in AT\/RT. Epigenetic dysregulation in other embryonal tumors with concomitant expression of stem-cell markers may facilitate HML-2 expression. Future studies could utilize HML-2 as potential diagnostic criteria, use its expression as a treatment biomarker, and investigate the efficacy of therapies targeting cells with high HML-2 expression.<\/jats:p>","DOI":"10.3390\/jpm11121332","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:07:18Z","timestamp":1639102038000},"page":"1332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors"],"prefix":"10.3390","volume":"11","author":[{"given":"Tara T.","family":"Doucet-O\u2019Hare","sequence":"first","affiliation":[{"name":"National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5941-9082","authenticated-orcid":false,"given":"Jared S.","family":"Rosenblum","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish H.","family":"Shah","sequence":"additional","affiliation":[{"name":"National Institutes of Neurological Disorders and Stroke (NINDS), Surgical Neurology Branch, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1073\/pnas.69.4.1009","article-title":"N.A.S. symposium: New evidence as the basis for increased efforts in cancer research","volume":"69","author":"Todaro","year":"1972","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1101\/SQB.1974.039.01.137","article-title":"Tumor viruses","volume":"39","author":"Baltimore","year":"1975","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-4690-3-67","article-title":"The discovery of endogenous retroviruses","volume":"3","author":"Weiss","year":"2006","journal-title":"Retrovirology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0042-6822(61)90056-3","article-title":"The properties of Rous sarcoma virus purified by density gradient centrifugation","volume":"13","author":"Crawford","year":"1961","journal-title":"Virology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/SQB.1962.027.001.038","article-title":"Separation of morphological conversion and virus production in Rous sarcoma virus infection","volume":"27","author":"Temin","year":"1962","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_6","first-page":"557","article-title":"Nature of the provirus of Rous sarcoma","volume":"17","author":"Temin","year":"1964","journal-title":"Nat. Cancer Inst. Monogr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0042-6822(66)90282-0","article-title":"Lack of relationship between infection with avian leukosis virus and the presence of COFAL antigen in chick embryos","volume":"29","author":"Dougherty","year":"1966","journal-title":"Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/2261209a0","article-title":"RNA-dependent DNA polymerase in virions of RNA tumor viruses","volume":"226","author":"Baltimore","year":"1970","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/2261211a0","article-title":"RNA-dependent DNA polymerase in virions of Rous sarcoma virus","volume":"226","author":"Temin","year":"1970","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"MDNA3-0009-2014","DOI":"10.1128\/microbiolspec.MDNA3-0009-2014","article-title":"Mammalian Endogeouns Retoviruses","volume":"3","author":"Mager","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.131.6.1659","article-title":"Nup120p: A yeast nucleoporin required for NPC distribution and mRNA transport","volume":"131","author":"Aitchison","year":"1995","journal-title":"J. Cell Biol."},{"key":"ref_13","first-page":"1","article-title":"Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta","volume":"91","author":"Germeyer","year":"2011","journal-title":"J. Reprod. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14308","article-title":"Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells","volume":"522","author":"Grow","year":"2015","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1128\/JVI.72.12.9782-9787.1998","article-title":"Human-specific integrations of the HERV-K endogenous retrovirus family","volume":"72","author":"Medstrand","year":"1998","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/jvi.69.1.414-421.1995","article-title":"Human endogenous retrovirus K10: Expression of Gag protein and detection of antibodies in patients with seminomas","volume":"69","author":"Sauter","year":"1995","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1073\/pnas.93.11.5177","article-title":"The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences","volume":"93","author":"Kurth","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","first-page":"17","article-title":"Nup120p: Antibodies to structural proteins of endogenous retrovirus of the HERV-K\/HDTV family as markers of human germ cell tumors","volume":"51","author":"Seniuta","year":"2006","journal-title":"Vopr. Virusol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-4690-8-90","article-title":"Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses","volume":"8","author":"Subramanian","year":"2011","journal-title":"Retrovirology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, W., Yang, L., Harris, R.S., Lin, L., Olson, T.L., Hamele, C.E., Feith, D.J., Loughran, T.P., and Poss, M. (2019). Retrovirus insertion site analysis of LGL leukemia patient genomes. BMC Med. Genom., 12.","DOI":"10.1186\/s12920-019-0549-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-10-16","article-title":"Endogenous retrovirus-K promoter: A landing strip for inflammatory transcription factors?","volume":"10","author":"Manghera","year":"2013","journal-title":"Retrovirology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-10-16","article-title":"A landing strip for inflammatory transcription factors?","volume":"10","author":"Wang","year":"2013","journal-title":"Retrovirology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2217\/epi-2020-0127","article-title":"Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients","volume":"12","author":"Cardelli","year":"2020","journal-title":"Epigenomics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"569015","DOI":"10.3389\/fonc.2020.569015","article-title":"Human Endogenous Retroviruses Long Terminal Repeat Methylation, Transcription, and Protein Expression in Human Colon Cancer","volume":"10","author":"Dolci","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2017.06.013","article-title":"LTR-Retrotransposon Control by tRNA-Derived Small RNAs","volume":"170","author":"Schorn","year":"2017","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cell.2018.02.028","article-title":"Chromatin Accessibility Landscape in Human Early Embros and Its Association with Evolution","volume":"173","author":"Gao","year":"2018","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"307ra153","DOI":"10.1126\/scitranslmed.aac8201","article-title":"Human endogenous retrovirus-K contributes to motor neuron disease","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.stem.2021.04.009","article-title":"Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3","volume":"28","author":"Nair","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/geno.1994.1383","article-title":"Molecular cloning of the cDNA for human TrkC (NTRK3), chromosomal assignment, and evidence for a splice variant","volume":"22","author":"McGregor","year":"1994","journal-title":"Genomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1038\/s41598-021-92223-x","article-title":"SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression","volume":"11","author":"DiSanza","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1742-4690-10-115","article-title":"Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells","volume":"10","author":"Fuchs","year":"2013","journal-title":"Retrovirology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"84093","DOI":"10.18632\/oncotarget.11455","article-title":"Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1158\/1078-0432.CCR-17-0001","article-title":"Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth","volume":"23","author":"Li","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/IGC.0b013e3182021c1a","article-title":"HERV-K hypomethylation in ovarian clear cell carcinoma is associated with a poor prognosis and platinum resistance","volume":"21","author":"Iramaneerat","year":"2011","journal-title":"Int. J. Gynecol. Cancer."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8201642","DOI":"10.1155\/2016\/8201642","article-title":"Human Endogenous Retroviruses-K (HML-2) Expression is Correlated with Prognosis and Progress of Hepatocellular Carcinoma","volume":"2016","author":"Ma","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1593\/neo.07986","article-title":"Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker","volume":"10","author":"Golan","year":"2008","journal-title":"Neoplasia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccell.2019.10.008","article-title":"Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors","volume":"36","author":"Leruste","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/14728222.2018.1451839","article-title":"Emerging therapeutic targets for the treatment of malignant rhabdoid tumors","volume":"22","author":"Nemes","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"586288","DOI":"10.3389\/fonc.2021.586288","article-title":"Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management","volume":"11","author":"Carta","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_40","first-page":"337","article-title":"Induction of retrovirus particles in human testicular tumor (Tera-1) cell cultures: An electron microscopic study","volume":"63","author":"Bronson","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_41","first-page":"1727","article-title":"Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors","volume":"149","author":"Herbst","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1128\/JVI.01016-08","article-title":"Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21","volume":"82","author":"Ruprecht","year":"2008","journal-title":"J. Virol."},{"key":"ref_43","first-page":"4362","article-title":"Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors","volume":"56","author":"Sauter","year":"1996","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-021-25709-x","article-title":"Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma","volume":"12","author":"DeSisto","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1002\/cam4.4245","article-title":"Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches","volume":"10","author":"Dahl","year":"2021","journal-title":"Cancer Med."},{"key":"ref_46","first-page":"15","article-title":"Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity","volume":"8","author":"Ishida","year":"2008","journal-title":"Cancer Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"658489","DOI":"10.3389\/fonc.2021.658489","article-title":"Ancient Adversary\u2014HERV-K(HML-2) in Cancer","volume":"11","author":"Dervan","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jnci\/djr540","article-title":"Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors","volume":"104","author":"Rycaj","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1158\/1078-0432.CCR-14-0388","article-title":"Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells","volume":"21","author":"Rycaj","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1158\/0008-5472.CAN-15-3139","article-title":"Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer","volume":"76","author":"Cherkasova","year":"2016","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI34409C1","article-title":"Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells","volume":"118","author":"Takahashi","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/JVI.73.3.2365-2375.1999","article-title":"Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus","volume":"73","author":"Berkhout","year":"1999","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ijc.24331","article-title":"The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells","volume":"125","author":"Rossi","year":"2009","journal-title":"Int. J. Cancer."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12307-019-00231-3","article-title":"The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs","volume":"12","author":"Giovinazzo","year":"2019","journal-title":"Cancer Microenviron."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Ibba, G., Piu, C., Uleri, E., Serra, C., and Dolei, A. (2018). Disruption by SaCas9 Endonuclease of HERV-Kenv, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis. Viruses, 10.","DOI":"10.3390\/v10080412"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.11649","article-title":"HERV-K(HML-2) GAG\/ENV antibodies as indicator for therapy effect in patients with germ cell tumors","volume":"110","author":"Kleiman","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpedsurg.2020.05.022","article-title":"Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers","volume":"56","author":"Grabski","year":"2021","journal-title":"J. Pediatr. Surg."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/12\/1332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:43:25Z","timestamp":1760168605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/12\/1332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jpm11121332"],"URL":"https:\/\/doi.org\/10.3390\/jpm11121332","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}